The functional Aquaporin 1 -783G/C-polymorphism is associated with survival in patients with glioblastoma multiforme

Journal of Surgical Oncology

Volumn 108, Issue 7, 2013, Pages 492-498

  El Hindy, Nicolai ^a   Rump, Katharina ^a   Lambertz, Nicole ^a   Zhu, Yuan ^a   Frey, Ulrich H ^a   Bankfalvi, Agnes ^a   Siffert, Winfried ^a   Sure, Ulrich ^a   Peters, Jürgen ^a   Adamzik, Michael ^a,b   Sandalcioglu, I Erol ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

2 year survival; aquaporin 1; glioblastoma multiforme; single nucleotide polymorphism

Indexed keywords

ANTINEOPLASTIC AGENT; AQUAPORIN 1; MESSENGER RNA;

ADULT; AGED; ALLELE; ARTICLE; BRAIN EDEMA; CANCER CHEMOTHERAPY; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENOTYPE; GLIOBLASTOMA; HIGH RISK PATIENT; HOMOZYGOSITY; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN METHYLATION; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; SURVIVAL;

2-YEAR SURVIVAL; AQUAPORIN 1; GLIOBLASTOMA MULTIFORME; SINGLE NUCLEOTIDE POLYMORPHISM;

AGED; ALLELES; AQUAPORIN 1; BRAIN NEOPLASMS; COHORT STUDIES; FEMALE; GLIOBLASTOMA; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOPLASM GRADING; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; PROPORTIONAL HAZARDS MODELS; RNA, MESSENGER; SURVIVAL RATE;

EID: 84887188864     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.23421     Document Type: Article

References (35)

1. Kleihues P, Louis DN, Scheithauer BW, et al.: The WHO classification of tumors of the nervous system. J Neuropathol Exp Neurol 2002; 61: 215-225, discussion 226-219. (Pubitemid 34212595)
2. Sant M, van der Sanden G, Capocaccia R:, Survival rates for primary malignant brain tumours in Europe. Eur J Cancer 1998; 34: 2241-2247. (Pubitemid 29036893)
3. Stupp R, van den Bent MJ, Hegi ME:, Optimal role of temozolomide in the treatment of malignant gliomas. Curr Neurol Neurosci Rep 2005; 5: 198-206. (Pubitemid 40873035)
4. Stupp R, Weber DC:, The role of radio- and chemotherapy in glioblastoma. Onkologie 2005; 28: 315-317. (Pubitemid 40827485)
5. Gorlia T, Stupp R, Brandes AA, et al.: New prognostic factors and calculators for outcome prediction in patients with recurrent glioblastoma: A pooled analysis of EORTC Brain Tumour Group phase I and II clinical trials. Eur J Cancer 2012; 48: 1176-1184.
6. Royds JA, Al Nadaf S, Wiles AK, et al.: The CDKN2A G500 allele is more frequent in GBM patients with no defined telomere maintenance mechanism tumors and is associated with poorer survival. PLoS ONE 2011; 6: e26737.
7. Semmler A, Simon M, Moskau S, et al. The methionine synthase polymorphism c.2756A>G alters susceptibility to glioblastoma multiforme. Cancer Epidemiol Biomarkers Prev 2006; 15: 2314-2316. (Pubitemid 44877063)
8. Simon M, Ludwig M, Fimmers R, et al.: Variant of the CHEK2 gene as a prognostic marker in glioblastoma multiforme. Neurosurgery 2006; 59: 1078-1085, discussion 1085. (Pubitemid 44852105)
9. El Hindy N, Adamzik M, Lambertz N, et al.: Association of the GNB3 825T-allele with better survival in patients with glioblastoma multiforme. J Cancer Res Clin Oncol 2010; 136: 1423-1429.
10. Oshio K, Binder DK, Bollen A, et al.: Aquaporin-1 expression in human glial tumors suggests a potential novel therapeutic target for tumor-associated edema. Acta Neurochir Suppl 2003; 86: 499-502.
11. Saadoun S, Papadopoulos MC, Davies DC, et al.: Increased aquaporin 1 water channel expression in human brain tumours. Br J Cancer 2002; 87: 621-623.
12. Papadopoulos MC, Saadoun S, Verkman AS:, Aquaporins and cell migration. Pflugers Arch 2008; 456: 693-700. (Pubitemid 351692135)
13. Kao SC, Armstrong N, Condon B, et al.: Aquaporin 1 is an independent prognostic factor in pleural malignant mesothelioma. Cancer 2011. 118: 2952-2961.
14. Otterbach F, Callies R, Adamzik M, et al.: Aquaporin 1 (AQP1) expression is a novel characteristic feature of a particularly aggressive subgroup of basal-like breast carcinomas. Breast Cancer Res Treat 2010; 120: 67-76.
15. Jiang Y:, Aquaporin-1 activity of plasma membrane affects HT20 colon cancer cell migration. IUBMB Life 2009; 61: 1001-1009.
16. Delporte C, Chen ZJ, Baum BJ:, Aquaporin 1 expression during the cell cycle in A5 cells. Biochem Biophys Res Commun 1996; 228: 223-228. (Pubitemid 26396058)
17. Lanahan A, Williams JB, Sanders LK, et al. Growth factor-induced delayed early response genes. Mol Cell Biol 1992; 12: 3919-3929.
18. Nico B, Ribatti D:, Role of aquaporins in cell migration and edema formation in human brain tumors. Exp Cell Res 2011; 317: 2391-2396.
19. Schoenegger K, Oberndorfer S, Wuschitz B, et al.: Peritumoral edema on MRI at initial diagnosis: An independent prognostic factor for glioblastoma ? Eur J Neurol 2009; 16: 874-878.
20. Arcienega II, Brunet JF, Bloch J, et al. Cell locations for AQP1, AQP4 and 9 in the non-human primate brain. Neuroscience 2010; 167: 1103-1114.
21. Bachmann HS, Siffert W, Frey UH:, Successful amplification of extremely GC-rich promoter regions using a novel 'slowdown PCR' technique. Pharmacogenetics 2003; 13: 759-766. (Pubitemid 38429253)
22. Frey UH, Kottenberg E, Kamler M, et al.: Genetic interactions in the beta-adrenoceptor/G-protein signal transduction pathway and survival after coronary artery bypass grafting: A pilot study. Br J Anaesth 2011; 107: 869-878.
23. Gutman DA, Cooper LA, Hwang SN, et al.: MR imaging predictors of molecular profile and survival: Multi-institutional study of the TCGA glioblastoma data set. Radiology 2013; 267: 560-569.
24. Hammoud MA, Sawaya R, Shi W, et al.: Prognostic significance of preoperative MRI scans in glioblastoma multiforme. J Neurooncol 1996; 27: 65-73. (Pubitemid 26052641)
25. El Hindy N, Keyvani K, Pagenstecher A, et al.: Implications of Dll4-Notch signaling activation in primary glioblastoma multiforme. Neuro Oncol 2013 [Epub ahead of print].
26. Mollemann M, Wolter M, Felsberg J, et al.: Frequent promoter hypermethylation and low expression of the MGMT gene in oligodendroglial tumors. Int J Cancer 2005; 113: 379-385. (Pubitemid 40038704)
27. Schaich M, Kestel L, Pfirrmann M, et al.: A MDR1 (ABCB1) gene single nucleotide polymorphism predicts outcome of temozolomide treatment in glioblastoma patients. Ann Oncol 2009; 20: 175-181.
28. Stark AM, van de Bergh J, Hedderich J, et al.: Glioblastoma: Clinical characteristics, prognostic factors and survival in 492 patients. Clin Neurol Neurosurg 2012; 114: 840-845.
29. Li Q, Zhang W, Zhang B:, [The correlation between the expression of AQP1 and angiogenesis ability in nasopharyngeal carcinoma]. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 2010; 24: 1115-1118.
30. Huang Y, Murakami T, Sano F, et al.: Expression of aquaporin 1 in primary renal tumors: A prognostic indicator for clear-cell renal cell carcinoma. Eur Urol 2009; 56: 690-698.
31. Echevarria M, Munoz-Cabello AM, Sanchez-Silva R, et al.: Development of cytosolic hypoxia and hypoxia-inducible factor stabilization are facilitated by aquaporin-1 expression. J Biol Chem 2007; 282: 30207-30215. (Pubitemid 350035297)
32. Abreu-Rodriguez I, Sanchez Silva R, Martins AP, et al.: Functional and transcriptional induction of aquaporin-1 gene by hypoxia; analysis of promoter and role of Hif-1alpha. PLoS ONE 2011; 6: e28385.
33. Hoque MO, Soria JC, Woo J, et al.: Aquaporin 1 is overexpressed in lung cancer and stimulates NIH-3T3 cell proliferation and anchorage-independent growth. Am J Pathol 2006; 168: 1345-1353.
34. Brennan C, Momota H, Hambardzumyan D, et al.: Glioblastoma subclasses can be defined by activity among signal transduction pathways and associated genomic alterations. PLoS ONE 2009; 4: e7752.
35. Phillips HS, Kharbanda S, Chen R, et al.: Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. Cancer Cell 2006; 9: 157-173. (Pubitemid 43357943)